Concepedia
Statistics
Publications
9
Citations
380
H-Index
Active since
2013
Affiliations
Johns Hopkins University(Current)
Tongji Hospital
Huazhong University of Science and Technology
Heinrich Heine University Düsseldorf
Düsseldorf University Hospital
Sean Dangelmajer is an author at Johns Hopkins University specializing in medicine, oncology, and regenerative medicine.
Publications per year
2013–2019
Hypoxia-cultured human adipose-derived mesenchymal stem cells are non-oncogenic and have enhanced viability, motility, and tropism to brain cancer
Yongzeng Feng, Mingxin Zhu, Sean Dangelmajer et al. · Cell Death and Disease · 2014 · 77 citations · Full text
Life Sciences, Cell Biology, Oncology +15
Isoflurane enhances the malignant potential of glioblastoma stem cells by promoting their viability, mobility in vitro and migratory capacity in vivo
Mingxin Zhu, Mingwu Li, Ya‐Qun Zhou et al. · British Journal of Anaesthesia · 2016 · 62 citations · Full text
Medicine, Cell Biology, Oncology +16
PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo
Romane Auvergne, Chun‐Ying Wu, Anne B. Connell et al. · Oncogene · 2015 · 50 citations
Medicine, Cancer Biology, Oncology +13
Transforming Growth Factor-β Promotes Homing and Therapeutic Efficacy of Human Mesenchymal Stem Cells to Glioblastoma
Man Li, Liang Zeng, Shengwen Liu et al. · Journal of Neuropathology & Experimental Neurology · 2019 · 45 citations · Full text
Medicine, Biotechnology, Oncology +17
Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma
Man Li, Shoujia Sun, Sean Dangelmajer et al. · Stem Cell Research & Therapy · 2019 · 38 citations · Full text
Pharmacy, Bioengineering, Oncology +17
1–5 of 9